Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impaired binding of drugs and endogenous ligands in renal diseases.

× No keyword cloud information.

12 in total

Review 1. Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors: R Zini; P Riant; J Barré; J P Tillement
Journal: Clin Pharmacokinet Date: 1990-09 Impact factor: 6.447

2. Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors: Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal: J Am Soc Nephrol Date: 2013-11-14 Impact factor: 10.121

Review 3. Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients.

Authors: T A Golper; W M Bennett
Journal: Med Toxicol Adverse Drug Exp Date: 1988 Sep-Oct

4. Can oral therapy reduce uremic toxins?

Authors: Thomas A Depner; Larry D Cowgill
Journal: Clin J Am Soc Nephrol Date: 2014-08-21 Impact factor: 8.237

5. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients.

Authors: Tammy L Sirich; Natalie S Plummer; Christopher D Gardner; Thomas H Hostetter; Timothy W Meyer
Journal: Clin J Am Soc Nephrol Date: 2014-08-21 Impact factor: 8.237

Review 6. Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors: W L St Peter; K A Redic-Kill; C E Halstenson
Journal: Clin Pharmacokinet Date: 1992-03 Impact factor: 6.447

7. Pharmacokinetics of etoposide in rats with uranyl nitrate (UN)-induced acute renal failure (ARF): optimization of the duration of UN dosing.

Authors: P Venkatesh; T Harisudhan; Hira Choudhury; Ramesh Mullangi; Nuggehally R Srinivas
Journal: Eur J Drug Metab Pharmacokinet Date: 2007 Oct-Dec Impact factor: 2.441

8. Production of antiserum for sensitive enzyme-linked immunosorbent assay of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid by chemiluminescence.

Authors: T Tanaka; H Ikebuchi; J Sawada; Y Tanaka
Journal: Lipids Date: 1998-07 Impact factor: 1.880

9. Quinine pharmacokinetics in chronic haemodialysis patients.

Authors: Louise Roy; Pierre Bannon; Jean-Pierre Villeneuve
Journal: Br J Clin Pharmacol Date: 2002-12 Impact factor: 4.335

Review 10. Clinical pharmacokinetics during continuous haemofiltration.

Authors: F Bressolle; J M Kinowski; J E de la Coussaye; N Wynn; J J Eledjam; M Galtier
Journal: Clin Pharmacokinet Date: 1994-06 Impact factor: 6.447